Literature DB >> 4974027

Vincristine neurotoxicity with hyponatremia.

L M Slater, R A Wainer, A A Serpick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4974027     DOI: 10.1002/1097-0142(196901)23:1<122::aid-cncr2820230114>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  11 in total

1.  Life-threatening hyponatremia caused by vinblastine.

Authors:  G Zavagli; G Ricci; G Tataranni; G Mapelli; V Abbasciano
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

2.  Hyponatremia in association with vincristine therapy.

Authors:  R G Nicholson; W Feldman
Journal:  Can Med Assoc J       Date:  1972-02-19       Impact factor: 8.262

Review 3.  Vincristine neurotoxicity. Pathophysiology and management.

Authors:  S S Legha
Journal:  Med Toxicol       Date:  1986 Nov-Dec

Review 4.  Hyponatremia related to medical anticancer treatment.

Authors:  T Berghmans
Journal:  Support Care Cancer       Date:  1996-09       Impact factor: 3.603

Review 5.  Drug-induced electrolyte abnormalities.

Authors:  E P Brass; W L Thompson
Journal:  Drugs       Date:  1982-09       Impact factor: 9.546

6.  Vincristine toxicity unrelated to dose.

Authors:  M J O'Callaghan; H Ekert
Journal:  Arch Dis Child       Date:  1976-04       Impact factor: 3.791

7.  Coma associated with vincristine therapy.

Authors:  J A Whittaker; D H Parry; C Bunch; D J Weatherall
Journal:  Br Med J       Date:  1973-11-10

8.  Acute encephalopathy associated with continuous vincristine sulfate combination therapy: case report.

Authors:  W Scheithauer; H Ludwig; E Maida
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

9.  Cisplatin-induced syndrome of inappropriate antidiuretic hormone secretion (SIADH) with life-threatening hyponatraemia.

Authors:  Aaron C Tan; Gavin M Marx
Journal:  BMJ Case Rep       Date:  2018-01-31

10.  Neurological toxicity of vindesine used in combination chemotherapy of 51 human solid tumors.

Authors:  C Focan; R Olivier; S Le Hung; R Bays; J J Claessens; H Debruyne
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.